Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
VASC's Cash to Debt is ranked higher than
86% of the 519 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. VASC: No Debt )
VASC' s 10-Year Cash to Debt Range
Min: 1.11   Max: No Debt
Current: No Debt

Equity to Asset 0.88
VASC's Equity to Asset is ranked higher than
94% of the 480 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. VASC: 0.88 )
VASC' s 10-Year Equity to Asset Range
Min: 0.34   Max: 0.96
Current: 0.88

0.34
0.96
Interest Coverage No Debt
VASC's Interest Coverage is ranked higher than
87% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 365.56 vs. VASC: No Debt )
VASC' s 10-Year Interest Coverage Range
Min: 48.63   Max: 9999.99
Current: No Debt

48.63
9999.99
F-Score: 4
Z-Score: 23.34
M-Score: -2.60
WACC vs ROIC
8.31%
16.90%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 14.51
VASC's Operating margin (%) is ranked higher than
89% of the 494 Companies
in the Global Medical Devices industry.

( Industry Median: 4.98 vs. VASC: 14.51 )
VASC' s 10-Year Operating margin (%) Range
Min: -1096.15   Max: 17.33
Current: 14.51

-1096.15
17.33
Net-margin (%) 9.28
VASC's Net-margin (%) is ranked higher than
85% of the 494 Companies
in the Global Medical Devices industry.

( Industry Median: 3.45 vs. VASC: 9.28 )
VASC' s 10-Year Net-margin (%) Range
Min: -1040.69   Max: 27.25
Current: 9.28

-1040.69
27.25
ROE (%) 11.24
VASC's ROE (%) is ranked higher than
85% of the 488 Companies
in the Global Medical Devices industry.

( Industry Median: 4.73 vs. VASC: 11.24 )
VASC' s 10-Year ROE (%) Range
Min: -72.4   Max: 72.44
Current: 11.24

-72.4
72.44
ROA (%) 9.92
VASC's ROA (%) is ranked higher than
91% of the 522 Companies
in the Global Medical Devices industry.

( Industry Median: 1.71 vs. VASC: 9.92 )
VASC' s 10-Year ROA (%) Range
Min: -67.48   Max: 42.87
Current: 9.92

-67.48
42.87
ROC (Joel Greenblatt) (%) 38.20
VASC's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 517 Companies
in the Global Medical Devices industry.

( Industry Median: 7.57 vs. VASC: 38.20 )
VASC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -2404.09   Max: 56.56
Current: 38.2

-2404.09
56.56
Revenue Growth (3Y)(%) 10.80
VASC's Revenue Growth (3Y)(%) is ranked higher than
87% of the 352 Companies
in the Global Medical Devices industry.

( Industry Median: 4.20 vs. VASC: 10.80 )
VASC' s 10-Year Revenue Growth (3Y)(%) Range
Min: 8.5   Max: 91.3
Current: 10.8

8.5
91.3
EBITDA Growth (3Y)(%) 8.70
VASC's EBITDA Growth (3Y)(%) is ranked higher than
82% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. VASC: 8.70 )
VASC' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -65.2   Max: 207.2
Current: 8.7

-65.2
207.2
EPS Growth (3Y)(%) 8.10
VASC's EPS Growth (3Y)(%) is ranked higher than
83% of the 315 Companies
in the Global Medical Devices industry.

( Industry Median: -2.50 vs. VASC: 8.10 )
VASC' s 10-Year EPS Growth (3Y)(%) Range
Min: -67.2   Max: 22.1
Current: 8.1

-67.2
22.1
» VASC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

VASC Guru Trades in Q2 2014

Jim Simons 386,706 sh (+27.92%)
Bill Frels 164,121 sh (+21.73%)
Chuck Royce 171,400 sh (+21.35%)
Mario Gabelli 266,771 sh (-6.09%)
Joel Greenblatt 19,877 sh (-19.10%)
» More
Q3 2014

VASC Guru Trades in Q3 2014

Mario Gabelli 266,771 sh (unchged)
Chuck Royce 171,400 sh (unchged)
Joel Greenblatt Sold Out
Bill Frels 161,170 sh (-1.80%)
Jim Simons 352,000 sh (-8.97%)
» More
Q4 2014

VASC Guru Trades in Q4 2014

Joel Greenblatt 8,442 sh (New)
Chuck Royce 190,300 sh (+11.03%)
Jim Simons 387,300 sh (+10.03%)
Bill Frels 156,073 sh (-3.16%)
Mario Gabelli 255,371 sh (-4.27%)
» More
Q1 2015

VASC Guru Trades in Q1 2015

Jim Simons 429,400 sh (+10.87%)
Joel Greenblatt Sold Out
Mario Gabelli 249,571 sh (-2.27%)
Chuck Royce 173,300 sh (-8.93%)
Bill Frels 114,373 sh (-26.72%)
» More
» Details

Insider Trades

Latest Guru Trades with VASC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 48.20
VASC's P/E(ttm) is ranked higher than
78% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. VASC: 48.20 )
VASC' s 10-Year P/E(ttm) Range
Min: 5.15   Max: 688.46
Current: 48.2

5.15
688.46
Forward P/E 31.25
VASC's Forward P/E is ranked higher than
75% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. VASC: 31.25 )
N/A
PE(NRI) 48.90
VASC's PE(NRI) is ranked higher than
82% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. VASC: 48.90 )
VASC' s 10-Year PE(NRI) Range
Min: 5.14   Max: 895
Current: 48.9

5.14
895
P/B 4.80
VASC's P/B is ranked higher than
57% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 3.93 vs. VASC: 4.80 )
VASC' s 10-Year P/B Range
Min: 2.37   Max: 17.18
Current: 4.8

2.37
17.18
P/S 4.40
VASC's P/S is ranked higher than
51% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. VASC: 4.40 )
VASC' s 10-Year P/S Range
Min: 1.37   Max: 10
Current: 4.4

1.37
10
PFCF 366.40
VASC's PFCF is ranked higher than
73% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. VASC: 366.40 )
VASC' s 10-Year PFCF Range
Min: 10.72   Max: 392.33
Current: 366.4

10.72
392.33
POCF 32.28
VASC's POCF is ranked higher than
81% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. VASC: 32.28 )
VASC' s 10-Year POCF Range
Min: 9.16   Max: 34.28
Current: 32.28

9.16
34.28
EV-to-EBIT 28.44
VASC's EV-to-EBIT is ranked higher than
83% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 568.20 vs. VASC: 28.44 )
VASC' s 10-Year EV-to-EBIT Range
Min: -485.1   Max: 387
Current: 28.44

-485.1
387
PEG 2.98
VASC's PEG is ranked higher than
96% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. VASC: 2.98 )
VASC' s 10-Year PEG Range
Min: 0.45   Max: 4.29
Current: 2.98

0.45
4.29
Shiller P/E 44.70
VASC's Shiller P/E is ranked higher than
82% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. VASC: 44.70 )
VASC' s 10-Year Shiller P/E Range
Min: 18.8   Max: 149.17
Current: 44.7

18.8
149.17
Current Ratio 5.17
VASC's Current Ratio is ranked higher than
85% of the 516 Companies
in the Global Medical Devices industry.

( Industry Median: 2.67 vs. VASC: 5.17 )
VASC' s 10-Year Current Ratio Range
Min: 1.94   Max: 26.32
Current: 5.17

1.94
26.32
Quick Ratio 4.00
VASC's Quick Ratio is ranked higher than
83% of the 516 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. VASC: 4.00 )
VASC' s 10-Year Quick Ratio Range
Min: 1.36   Max: 25.52
Current: 4

1.36
25.52
Days Inventory 134.53
VASC's Days Inventory is ranked higher than
76% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 172.71 vs. VASC: 134.53 )
VASC' s 10-Year Days Inventory Range
Min: 130.39   Max: 240.65
Current: 134.53

130.39
240.65
Days Sales Outstanding 50.60
VASC's Days Sales Outstanding is ranked higher than
89% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 86.69 vs. VASC: 50.60 )
VASC' s 10-Year Days Sales Outstanding Range
Min: 38.82   Max: 116.17
Current: 50.6

38.82
116.17

Valuation & Return

vs
industry
vs
history
Price/Net Cash 32.40
VASC's Price/Net Cash is ranked higher than
78% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. VASC: 32.40 )
VASC' s 10-Year Price/Net Cash Range
Min: 0.59   Max: 539.5
Current: 32.4

0.59
539.5
Price/Net Current Asset Value 14.30
VASC's Price/Net Current Asset Value is ranked higher than
75% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. VASC: 14.30 )
VASC' s 10-Year Price/Net Current Asset Value Range
Min: 0.5   Max: 28.94
Current: 14.3

0.5
28.94
Price/Tangible Book 6.10
VASC's Price/Tangible Book is ranked higher than
62% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 7.69 vs. VASC: 6.10 )
VASC' s 10-Year Price/Tangible Book Range
Min: 0.68   Max: 10.77
Current: 6.1

0.68
10.77
Price/DCF (Projected) 2.60
VASC's Price/DCF (Projected) is ranked higher than
82% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. VASC: 2.60 )
VASC' s 10-Year Price/DCF (Projected) Range
Min: 1.34   Max: 130.33
Current: 2.6

1.34
130.33
Price/Median PS Value 1.70
VASC's Price/Median PS Value is ranked higher than
55% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 1.30 vs. VASC: 1.70 )
VASC' s 10-Year Price/Median PS Value Range
Min: 0.3   Max: 12.58
Current: 1.7

0.3
12.58
Price/Peter Lynch Fair Value 4.10
VASC's Price/Peter Lynch Fair Value is ranked higher than
93% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. VASC: 4.10 )
VASC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.23   Max: 8.67
Current: 4.1

0.23
8.67
Price/Graham Number 3.60
VASC's Price/Graham Number is ranked higher than
79% of the 582 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. VASC: 3.60 )
VASC' s 10-Year Price/Graham Number Range
Min: 0.89   Max: 10.83
Current: 3.6

0.89
10.83
Earnings Yield (Greenblatt) 3.60
VASC's Earnings Yield (Greenblatt) is ranked higher than
79% of the 507 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. VASC: 3.60 )
VASC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.3   Max: 10.3
Current: 3.6

0.3
10.3
Forward Rate of Return (Yacktman) 13.66
VASC's Forward Rate of Return (Yacktman) is ranked higher than
91% of the 219 Companies
in the Global Medical Devices industry.

( Industry Median: 3.92 vs. VASC: 13.66 )
VASC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -57.3   Max: 54.1
Current: 13.66

-57.3
54.1

Business Description

Industry: Medical Devices » Medical Devices
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:VA4.Germany,
Vascular Solutions Inc was incorporated in the state of Minnesota in December 1996. It is a medical device company, creates new minimally invasive medical devices, and delivers these products and related services to physicians through its direct domestic sales force and its international distribution network. The Companys products and services are divided into three categories: Catheter products; Hemostat products and Vein products and services. Catheter products consist principally of catheters used in minimally invasive medical procedures for the diagnosis or treatment of vascular conditions, such as the GuideLiner catheter used to access discrete regions of the coronary anatomy and the Pronto extraction catheters used in treating acute myocardial infarction. Hemostat products consist principally of blood clotting products, such as the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat Flowable, a thick yet flowable thrombin-based mixture for preventing bleeding in subcutaneous pockets. Vein products and services consist principally of the Vari-Lase endovenous laser, a laser console and procedure kit used for the treatment of varicose veins, and a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter. The Company manufactures its products in its facilities located in the suburbs of Minneapolis, Minnesota and in the country of Ireland. The catheter manufacturing and packaging processes occur under a controlled clean room environment. It purchases components from various suppliers and rely on single sources for several parts of its products. It purchases its requirements for thrombin for use in manufacturing products sold in the U.S. under the Thrombin-JMI Supply Agreement with King. Its main competitors include: Medtronic, Boston Scientific, Covidien, Merit Medical, Marine Polymer Technologies, Cook Medical, Spectranetics, AngioDynamics and Terumo. The Companys products and services are regulated in the United States as medical devices by the FDA under the Federal Food, Drug and Cosmetic Act.
» More Articles for VASC

Headlines

Articles On GuruFocus.com
Vascular Solutions Inc. Reports Operating Results (10-K) Feb 01 2011 
Vascular Solutions Inc. (VASC) CEO Howard Root sells 25,000 Shares Nov 04 2010 
Vascular Solutions Inc. Reports Operating Results (10-K) Feb 02 2010 
Vascular Solutions Inc. Reports Operating Results (10-Q) Apr 17 2009 
Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call Tuesday, February 3, 2009 at 3:30 Jan 08 2009 

More From Other Websites
Zacks.com featured expert Kevin Matras highlights: SVB Financial Group, AMC Networks, Vascular... May 06 2015
VASCULAR SOLUTIONS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 04 2015
Nasdaq stocks posting largest percentage increases Apr 29 2015
Vascular Solutions To Participate In Bank Of America Merrill Lynch 2015 Health Care Conference Apr 29 2015
Vascular Solutions to Participate in Bank of America Merrill Lynch 2015 Health Care Conference Apr 29 2015
Chemed Posts Stellar Q1; Beats on Earnings and Revenues - Analyst Blog Apr 29 2015
Vascular Solutions Stock: 3 Reasons Why It Is a Top Choice for Growth Investors - Tale of the Tape Apr 27 2015
VASCULAR SOLUTIONS INC Financials Apr 25 2015
10-Q for Vascular Solutions, Inc. Apr 23 2015
Vascular Solutions discloses indicted CEO's pay and business risk Apr 22 2015
VASCULAR SOLUTIONS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... Apr 22 2015
Vascular Solutions posts 1Q profit Apr 21 2015
Vascular Solutions posts 1Q profit Apr 21 2015
Vascular Solutions Reports First Quarter Results Apr 21 2015
VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 21 2015
Vascular Solutions Reports First Quarter Results Apr 21 2015
Q1 2015 Vascular Solutions Inc Earnings Release - After Market Close Apr 21 2015
Vascular Solutions Announces Q1 Earnings Date Mar 31 2015
Vascular Solutions, Inc. to Webcast First Quarter Conference Call Mar 31 2015
Vascular Solutions Launches PolarCath™ Peripheral Dilatation System Mar 16 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK